Engaging Thought Leadership
Over 45 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
Gene Therapy Development 2024
13 - 14 June 2024 | London, UK
Gene Therapy Development 2024
Meet Our Expert Speakers
Gene Therapy Development 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Below are some of our featured speakers:
Alba Guijarro Belmar
Head of Vector Development,
Sania Therapeutics
Alberto del Rio Espinola
Director,
GentiBio Inc
Amin Hajitou
Professor,
Imperial College London
Charlotte Smerdon
Senior Director, Clinical Operations,
Purespring Therapeutics
Giandomenico Turchiano
Associate Director,
UCL/AstraZeneca
James Norton
Director analytical development,
MeiraGTx
Jane Kinghorn
Director Translational Research Office,
University College London
Johnson Varghese
Head of Analytical Development,
BeamTx
Lilian Hook
Director Cell, Apheresis and Gene Therapies,
NHS Blood and Transplant
Nathalie Cartier-Lacave
Senior Vice President Neurobiology,
AskBio
Breech Conrad Odu
Process Development Scientist,
Merck Life Sciences
Chrysanthi Sitmalidou
Scientist II,
Orchard Therapeutics
Claudio Mussolino
Group Leader,
Medical Center - University of Freiburg
De Cupere Vinciane
technical lead,
UCB
Elina Hessels
Associate Director Analytical Platforms,
uniQure
Ellina Allais
Regulatory Affairs Senior Director,
Cellectis S.A.
Eugenio Macchiarulo
Director MSAT,
Barinthus Bio
Khalid Saeed
Senior Scientist,
AstraZeneca
Koval Smith
Snr Manager,
Orchard
Lily li
lead scientist,
aviadobio
Mana Yen
Gene Therapies - Global Head of Health Systems and Policy at Novartis Gene Therapies.,
Novartis
Michel Degueldre
Lead GT Biophysical Sciences,
UCB
Nina Kotsopoulou
Chief Technology Officer,
Xap Therapeutics
Pamela Whalley
Associate Director, CMC,
Complement Therapeutics
Patricia Lareo
Value Chain Capability Lead Gene Therapy,
Roche
Peter Pechan
Head of Vector Biology and Discovery,
UCB
Yen Choo
Founder & Chairman; Associate Professor of Stem Cell Science and Regenerative Medicine,
Plasticell; Lee Kong Chian School of Medicine Science
Yu-Tsan (Richard) Liu
Sr. Scientist,
UCB Pharma
Meet Our Esteemed Sponsors
Silver Sponsors
Progen Biotechnik GmbH
Silver Sponsor
PROGEN was founded in 1983 by four scientists from Heidelberg, Germany, who joined forces to manufacture and supply high quality antibodies for biomedical research. We help scientists worldwide drive biopharmaceutical and diagnostic progress to provide high-quality and reliable treatments for patients. Our mission is to make new therapies safe and affordable and to improve existing research processes. The PROGEN team consists of bioscientists and adeno-associated virus (AAV) experts who collaborate with specialists around the world. Our products are essentials for research in science and industry. We are more than just a manufacturer of antibodies, AAV gene therapy tools, density gradient media, and phage display technologies: We strive to understand the needs of scientists to develop solutions to jointly address challenges in academic research, biotechnology and pharma.
Sartorius BIA Separations
Silver Sponsor
Sartorius BIA Separations develops and manufactures market-leading CIM® monolithic chromatographic columns for the purification and analysis of large biomolecules, such as viruses, plasmids, and mRNA, which are applied in cell and gene therapies. The company’s Cornerstone® Biomanufacturing Development Services are the result of more than 25 years of hands-on experience with the most challenging biopharmaceutical products and offer a comprehensive approach of integrated process development solutions and novel technology designed to improve the robustness and yield of large biomolecules production while improving the safety of therapeutic products. Sartorius BIA's technology for manufacturing-scale purification is already used in the production of the first commercialized advanced therapeutics;the company also has a keen presence with novel drug candidates in the clinical pipeline.
Bronze Sponsors
Promega UK Ltd
Bronze Sponsor
Promega are world leaders in providing innovative solutions and technical support to life science research. Over 4,000 products enable scientists to advance their knowledge in cellular analysis, genomics and proteomics, promoting understanding of the molecular basis of life and potential mechanisms of disease, as well as identifying targets for drug development.
Rapid Micro Biosystems
Bronze Sponsor
At Rapid Micro Biosystems, we are dedicated to providing groundbreaking technology and products to support biomanufacturing companies in their mission to deliver the highest possible quality products for improved patient outcomes. Thanks to our unmatched expertise in science and technology, we are a trusted partner of healthcare product manufacturers around the world. Rapid Micro Biosystems is headquartered and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. Our Growth Direct® System is a growth-based technology platform that fully automates the traditional compendial method of quality control (QC) microbiology testing in mission-critical applications such as environmental monitoring, water testing, and bioburden testing. It detects contamination more quickly, supports improved QC processes, and delivers compelling economic benefits. By replacing slow, error-prone manual processes, the Growth Direct® System does much more than decrease error, ensure data integrity, and reduce the risk of costly contamination events. It also enables manufacturers to accelerate timelines, maximize capacity, and reduce operational risk and downtime. This results in better, more cost-effective pharmaceuticals, biologics, biotech products, medical devices, and personal care products.
Rentschler Biopharma
Bronze Sponsor
Rentschler Biopharma is a leading global CDMO, focused exclusively on client projects. Thanks to our 50 years of proven scientific expertise in biotechnology, we count ourselves among the leaders in the industry. From our headquarters in Laupheim, Germany, and our sites in Milford, USA, and Stevenage, UK, we offer end-to-end solutions including biopharmaceutical and viral vector process development and cGMP manufacturing. Our Center of Excellence for advanced therapies is located in Stevenage, UK, the largest cell and gene therapy cluster in Europe. At Rentschler Biopharma's Stevenage site, we are dedicated to advancing viral vector products from development to cGMP manufacturing of high quality advanced therapies for our clients and their patients.
Thermo Fisher Scientific
Bronze Sponsor
Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex therapy challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.
Network & Programme Sponsors
Advanced Instruments
Network & Programme Sponsor
Advanced Instruments is a global provider of scientific and analytical solutions for the biopharma and clinical industries Our company’s innovations have helped organizations improve quality, achieve reliable outcomes, and increase productivity for more than 65 years. Our focus on service, quality, and reliability has made us a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries. Our newest addition, the Artel portfolio, includes leading analytical instruments, software and services that validate, automate, and calibrate critical liquid handling processes and instrumentation. Our Solentim portfolio delivers best-in-class imaging and single-cell deposition technologies for cell line development workflows. And our OsmoTECH® and OsmoPRO® micro-osmometers support the workflows that labs worldwide rely on for the delivery of accurate and timely results.
Benchling UK Ltd
Network & Programme Sponsor
Benchling is the pioneer of the R&D Cloud, software that powers the biotechnology industry. More than 200,000 scientists at over 900 companies and 7,500 research institutions globally have adopted Benchling's R&D Cloud to make breakthrough discoveries and bring the next generation of medicines, food, and materials to market faster than ever before. The R&D Cloud helps these organizations modernize their scientific processes and accelerate collaboration so they can convert the complexity of biology into world-changing results. For more, please visit Benchling.com.
Biocair
Network & Programme Sponsor
Biocair is an award-winning GDP logistics specialist, working in the pharmaceutical, biotechnology and life sciences sectors since 1986. Biocair has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance. Each logistics solution is built around our core service by the dedicated, global Cell & Gene Therapy Logistics Team and handled by our supply chain management experts throughout its journey.
Cryoport Systems
Network & Programme Sponsor
Cryoport Systems is a comprehensive supply chain partner for the life sciences industry focused on meeting the challenges of the global cell and gene therapy market. We excel in the specialized management of the biopharmaceutical supply chain through our comprehensive offerings in logistics, BioServices and biostorage, cryopreservation, and consulting. Our expansive offerings are fully integrated to create a comprehensive platform that helps deliver risk mitigation, transparency, and certainty. With our expansive platform and decades of temperature-controlled supply chain expertise, Cryoport Systems helps Enable the Outcome for organizations from initial research through global commercialization.
NOF Europe
Network & Programme Sponsor
NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators.
SGS Vitrology
Network & Programme Sponsor
With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers and finished products. SGS provides a comprehensive range of biosafety services such as: virology, cell and molecular biology, microbiology and TEM. Health Authorities (US FDA and the EMA), require companies to undergo safety testing demonstrating that cell banks, viral banks, raw materials, bulk harvests, and batches of clinical drug are free of bacteria, fungi, mycoplasma, viruses and other potential contaminants. SGS ensures product safety in satisfying these regulatory requirements.
TATAA
Network & Programme Sponsor
TATAA Biocenter specializes in providing regulated molecular analysis laboratory services for biopharmaceutical clients. Committed to quality, innovation, and fostering strong client relationships, we serve as your trusted partner to accelerate drug development. As a contract research organization, we offer clients the latest technologies and generate accurate and reproducible data that shortens time-to-market. TATAA’s core focus is delivering high-quality, high-throughput bioanalysis for cell and gene therapies and biomarker profiling for precision medicine. Integral to the success of every study with TATAA Biocenter is the team of highly skilled scientists with extensive experience in nucleic acid analyses and knowledge of regulatory requirements.
Jaguar Gene's JAG201 Therapy Trial for SHANK3 Haploinsufficiency Receives FDA Approval
JAG201 gene replacement therapy available to both child and adult patients is now in Phase I clinical trial.
Reshaping Genome Editing: Doudna & Charpentier, the Founders of CRISPR/Cas9 and Their Legacy
In 2020 Jennifer Doudna & Emmanuelle Charpentier were awarded the Nobel Prize in Chemistry for discovering the revolutionary gene-editing tool CRISPR/Cas9. This article shines a spotlight on their remarkable achievements and addresses current applications and future opportunities for CRISPR/Cas9.
SGS Biologics Services
SGS Biosafety & Characterisation Services
SGS Cell & Gene Therapies
Is Single-Use Bioprocessing the Way Forward?
Danish company Novo Holdings has acquired a majority stake in the Austrian-based company Single Use Support, marking a critical stride towards the wider adoption of single-use bioprocessing tools.
ILEC Conference Centre
47 Lillie Rd
London
SW6 1UD
United Kingdom
By Underground
Sitting at the edge of zone 1, West Brompton and Earls Court stations are both within walking distance giving easy access to all central districts of London and Heathrow Airport. Transport for London tube map.
By Car
ILEC is a quarter of a mile (400m) from the A4, providing easy access to the M4, M5 and M40.
By Air
Heathrow (LHR): 21 km - Approximately 30 minutes in light traffic. You can also reach the airport directly by London Underground, on the Piccadilly line. Gatwick (LGW): 45 Km - Approximately an hour in light traffic. It is 40 minutes by train from West Brompton station via Clapham Junction. Direct shuttle available with Easy Bus. London City (LCY): 21 km - Approximately 45 minutes in light traffic.
Parking
There is a car park adjacent to ILEC with 140 parking bays. The parking is NOT managed by ILEC so spaces cannot be reserved and may become full during busy events. Guests and delegates can benefit from preferential parking rates as follows: Up to 2 hours £7 Up to 4 hours £11 Up to 6 hours £14 Up to 9 hours £16 (£21 for non-residents) Up to 12 hours £20 (£26 for non-residents) Up to 24 hours (overnight) £26
Oxford Global have secured a number of bedrooms at ibis London Earls Court at a reduced rate:
Wednesday 12th June 2024 – £176, breakfast included
Thursday 13th June 2024 – £176, breakfast included
Should you wish to book a room, please click here.
The final cut-off date to book bedrooms is Monday 27th May 2024 – any bookings after this date are subject to availability and rates. Please note, that any cancellations within 14 days prior to arrival are subject to cancellation charges.
Additionally, we kindly remind all attendees to only book their accommodation if they are registered for the event. This ensures that accommodations are available for those who have officially secured their attendance.
We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.
As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.
Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.
Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.
If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Gene Therapy Development 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.
